Using tiny implants filled with lab-grown pancreatic cells (known as VC-02), researchers found the need for insulin shots among people with type 1 diabetes was significantly reduced, according to a new study published in Nature...Read More »
Q: What is the pathway for mortality cases at your organization? We review the mortality cases that have a risk of mortality (ROM) and severity of illness score of 4 or below, and to improve the observed to expected ratio (O:E). The workflow, however, is inefficient, and the CDI team...Read More »
There simply aren’t enough places to showcase CDI excellence and success. But if your team has started an initiative, finished a project, or made an impact and you want to share it with the national CDI community, an ACDIS poster might be the perfect medium for it! Right now, ACDIS is accepting...Read More »
One of our main goals at ACDIS is to support and help each individual member shine, and there’s never a better opportunity to do so than our ACDIS Achievement Awards! If you are looking to recognize your incredible CDI colleagues for all the work they do, we encourage you to nominate them for...Read More »
The ACDIS team has so enjoyed this year of an updated, CEU-offering ACDIS Podcast. We want to make sure everyone receives the CEUs they’ve earned, so if you’ve had any issues with receiving yours after listening in during the CEU period and...Read More »
It’s almost that time of year again, chapter leaders! As always, ACDIS national strives to work in concert with ACDIS local chapters to allow for opportunities to network, share resources, obtain educational opportunities, and enhance the mission of the CDI profession. In the ACDIS Local Chapter...Read More »
If your 2023 has looked anything like mine, there have been good times, but also plenty of changes and challenges to overcome. As this exciting, crazy year comes to a close, now is a great time to consider what you’ve learned and can bring with you into the next...Read More »
An experimental therapy restored executive function in patients with moderate to severe traumatic brain injury (msTBI) and chronic sequelae, according a recent study published in Nature Medicine. The therapy includes using...Read More »
